Literature DB >> 7057857

Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects.

G Lister, W E Hellenbrand, C S Kleinman, N S Talner.   

Abstract

We studied the acute effects of increasing hemoglobin concentration and hematocrit on the pulmonary and systemic circulations of nine infants with large left-to-right shunts. After isovolemic exchange transfusion, which was designed to raise hemoglobin but keep blood volume constant, a consistent rise in systemic and pulmonary vascular resistances occurred. This rise was comparable to those previously found in isolated circulations showing a linear relation between hematocrit and loge of the vascular resistance. These changes in resistance were accompanied by decreases in systemic and pulmonary blood flow and a marked decline in left-to-right shunt. Despite the decrease in systemic blood flow, there was no decline in systemic oxygen transport, and there may have been a marginal decrease in left ventricular stroke work. These observations help explain why the newborn with a large ventricular septal defect and a high hemoglobin concentration does not have clinical signs of a large left-to-right shunt, and also suggest that the postnatal decline in hematocrit has a substantial role in the normal fall in pulmonary vascular resistance after birth.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057857     DOI: 10.1056/NEJM198203043060902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  8 in total

1.  Haematocrit and red blood cell transport in preterm infants: an observational study.

Authors:  P Pladys; A Beuchée; E Wodey; L Tison; P Bétrémieux
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 2.  Changes of the cardiovascular system during the perinatal period.

Authors:  H Stopfkuchen
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

3.  Effects of pentoxifylline (Trental) on blood flow, viscosity, and oxygen transport in young adults with inoperable cyanotic congenital heart disease.

Authors:  W Berman; N Berman; D Pathak; S C Wood
Journal:  Pediatr Cardiol       Date:  1994 Mar-Apr       Impact factor: 1.655

4.  Hemodynamic correlates of clinical severity in isolated ventricular septal defect.

Authors:  S S Gidding; M Bessel
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

5.  Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Jill M Cholette; Ariane Willems; Stacey L Valentine; Scot T Bateman; Steven M Schwartz
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

6.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

7.  Ductal closure in infants under 6 kg including premature infants using AmplatzerTM duct occluder type two additional sizes: a single-centre experience in South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Makrexeni; Samkelo Jiyana
Journal:  Cardiovasc J Afr       Date:  2019-08-30       Impact factor: 1.167

8.  Acute Effects of Hypoxic Gas Admixtures on Pulmonary Blood Flow and Regional Oxygenation in Children Awaiting Norwood Palliation.

Authors:  Lisha Thomas; Saul Flores; Joshua Wong; Rohit Loomba
Journal:  Cureus       Date:  2019-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.